Search Results 691-700 of 19264 for Hemoglobin

1. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet count >100 X 10(9). Exclusion Criteria: History of HIV; Presence of active infection; New York Hear ...

2. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

   ... Hemoglobin A1c ≥7%; Part 2c: Patients with uncontrolled diabetes or Hemoglobin A1c >8%. Patients with glucose intolerance or diabetes whose blood glucose ...

3. Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min ...

4. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; For the hematologic malignancy patients, blood count values cited above do not apply. Prothrombin time (PT) or International Normalized ...

5. A Study to Evaluate the Long-Term Safety and Effectiveness of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   Hemoglobin concentration < 9 g/dL at screening. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most ...

6. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

   Able to swallow whole capsules [Pending availability of granule formulation]. 6. Hematologic Function: Absolute neutrophil count ≥ 1200/µL, hemoglobin ≥ 9g/dL ...

7. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min using the Cockcroft-Gault formula. Female CrCl = (140 - age ...

8. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope GFR ≥ 70 mL/min/1.73 m²; OR serum creatinine ...

9. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Hemoglobin >= 8.0 g/dL (=< 28 days prior to registration) - Without growth factor support, blood transfusion, or platelet stimulating agents for the past ...

10. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

    Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with creatinine clearance ≥ 50 mL/min using the Modified Cockcroft-Gault method ...